ArticlePharmaceuticals (Basel, Switzerland)2025
Correction: Hou et al. S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer.
Zhenyan Hou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.